Grape Seed Proanthocyanidins Inhibit Replication of the Dengue Virus by Targeting NF-kB and MAPK-Mediated Cyclooxygenase-2 Expression

Viruses. 2023 Mar 30;15(4):884. doi: 10.3390/v15040884.

Abstract

Dengue virus (DENV) infection is a serious global health issue as it causes severe dengue hemorrhagic fever and dengue shock syndrome. Since no approved therapies are available to treat DENV infection, it is necessary to develop new agents or supplements that can do this. In this study, grape seed proanthocyanidins extract (GSPE), which is widely consumed as a dietary supplement, dose-dependently suppressed the replication of four DENV serotypes. The inhibitory mechanism demonstrated that GSPE downregulated DENV-induced aberrant cyclooxygenase-2 (COX-2) expression, revealing that the inhibitory effect of the GSPE on DENV replication involved targeting DENV-induced COX-2 expression. Mechanistic studies on signaling regulation have demonstrated that GSPE significantly reduced COX-2 expression by inactivating NF-κB and ERK/P38 MAPK signaling activities. Administrating GSPE to DENV-infected suckling mice reduced virus replication, mortality, and monocyte infiltration of the brain. In addition, GSPE substantially reduced the expression of DENV-induced inflammatory cytokines associated with severe dengue disease, including tumor necrosis factor-α, nitric oxide synthase, interleukin (IL)-1, IL-6, and IL-8, suggesting that GSPE has potential as a dietary supplement to attenuate DENV infection and severe dengue.

Keywords: cyclooxygenase; dengue virus; grape seed extract; inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclooxygenase 2 / genetics
  • Dengue Virus* / physiology
  • Dengue*
  • Mice
  • NF-kappa B / metabolism
  • Severe Dengue* / drug therapy
  • Virus Replication

Substances

  • Grape Seed Proanthocyanidins
  • NF-kappa B
  • Cyclooxygenase 2

Grants and funding

This research was funded by the Ministry of Science and Technology of Taiwan (under grant numbers MOST111-2311-B-110-001 and MOST110-2314-B-037-117-MY2), the NSYSU-KMU Joint Research Project (#NSYSYKMU 111-I06), and the Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation, Taiwan (grant number 109 CM-KMU-006).